Cargando…
Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinoma
A poor outcome for pancreatic ductal adenocarcinoma (PDAC) patients is still a challenge worldwide. The aim of our study is to investigate the potential of key laminin subunits for being used both as a diagnostic and prognostic biomarker for PDAC patients. We evaluated the mRNA expression and progno...
Autores principales: | Yang, Chengkun, Liu, Zhengqian, Zeng, Xianmin, Wu, Qiongyuan, Liao, Xiwen, Wang, Xiangkun, Han, Chuangye, Yu, Tingdong, Zhu, Guangzhi, Qin, Wei, Peng, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594799/ https://www.ncbi.nlm.nih.gov/pubmed/31182680 http://dx.doi.org/10.18632/aging.102007 |
Ejemplares similares
-
Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early-stage pancreatic ductal adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019) -
Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019) -
Diagnostic and prognostic value of mRNA expression of phospholipase C β family genes in hepatitis B virus-associated hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019) -
Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy
por: Liao, Xiwen, et al.
Publicado: (2018) -
Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
por: Liao, Xiwen, et al.
Publicado: (2018)